May 16, 2017
Boston, MA
Please join us for a discussion of antibody patent prosecution, enforcement, and defense; case law and regulatory updates impacting biosimilar and pharmaceutical products; and recent decisions involving patent-eligible subject matter. Specifically, we will address:
Speakers:
Jeffrey M. Jacobstein
Alissa K. Lipton
Jill K. MacAlpine, Ph.D.
Leslie A. McDonell
Amanda K. Murphy, Ph.D.
Linda A. Wadler
Marta Garcia Daneshvar
Tuesday, May 16, 2017
8:30 - 9:00 a.m.
Registration and Breakfast
9:00 - 11:45 a.m.
Workshop
11:45 a.m. - 12:30 p.m.
Working Lunch
12:30 - 3:00 p.m.
Workshop
Location:
Finnegan
Two Seaport Lane
Boston, MA 02210
RSVP: To attend, please register by Friday, May 12, 2017. Space is limited.
Parking: Complimentary parking is available in the Seaport Garage. Please enter through the D Street entrance and bring your parking ticket to the reception area for validation.
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.